A

Abcuro

HealthRare Diseases

Abcuro is a biotechnology company focused on developing therapies for rare inflammatory disorders. The company aims to address unmet medical needs in conditions that currently lack approved treatments, making their work particularly significant in the healthcare landscape.

Visit website ↗
Total raised
$66M
tracked to date
Latest round
$66M
Aug 23, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    $66MAug 23, 2026
    Announcement ↗

Abcuro in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile